Pairawan S, Zhao M, Yuca E, Annis A, et al. First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models. Breast Cancer Res 2021;23:29.
PMID: 33663585